Your browser doesn't support javascript.
loading
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.
Mitsui, Yuichi; Suzuki, Tatsuya; Kuniyoshi, Kanako; Inamo, Jun; Yamaguchi, Kensuke; Komuro, Mariko; Watanabe, Junya; Edamoto, Mio; Li, Songling; Kouno, Tsukasa; Oba, Seiya; Hosoya, Tadashi; Masuhiro, Kentaro; Naito, Yujiro; Koyama, Shohei; Sakaguchi, Nobuo; Standley, Daron M; Shin, Jay W; Akira, Shizuo; Yasuda, Shinsuke; Miyazaki, Yasunari; Kochi, Yuta; Kumanogoh, Atsushi; Okamoto, Toru; Satoh, Takashi.
Afiliación
  • Mitsui Y; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Suzuki T; Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Department of Microbiology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
  • Kuniyoshi K; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Inamo J; Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Yamaguchi K; Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Komuro M; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Watanabe J; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Edamoto M; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Li S; Laboratory of Systems Immunology, World Premier Institute Immunology Frontier Research Center, WPI-IFReC, Osaka University, Osaka 565-0871, Japan.
  • Kouno T; RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
  • Oba S; Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Hosoya T; Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Masuhiro K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Naito Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Koyama S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Sakaguchi N; Innate Cell Therapy Inc., Osaka 530-0017, Japan.
  • Standley DM; Laboratory of Systems Immunology, World Premier Institute Immunology Frontier Research Center, WPI-IFReC, Osaka University, Osaka 565-0871, Japan.
  • Shin JW; RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
  • Akira S; Innate Cell Therapy Inc., Osaka 530-0017, Japan; Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center, WPI-IFReC, Osaka University, Osaka 565-0871, Japan.
  • Yasuda S; Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Kochi Y; Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
  • Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Okamoto T; Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan; Department of Microbiology, Juntendo University School of Medicine, Tokyo 113
  • Satoh T; Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan; Innate Cell Therapy Inc., Osaka 530-0017, Japan. Electronic address: satoh.mbch@tmd.ac.jp.
Immunity ; 56(8): 1939-1954.e12, 2023 08 08.
Article en En | MEDLINE | ID: mdl-37442134
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article